The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

NSCLC · Stereotactic Body Radiation Therapy (SBRT) · Immunotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Zhengfei Zhu) · fuscczzf@163.com · +86-18017312901

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE

NSCLC · Neoadjuvant Chemoimmunotherapy · CT

Abroad (travel likely)Recruiting

Seoul, South Korea

Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC

NSCLC · Neoadjuvant Immunotherapy · Low Dose Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Hefei, China

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Carcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Hinsdale, United States · New Lenox, United States